Brief: N2OFF Announces Closing of Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
23/10/2025 13:25
Oct 23 (Reuters) - N2OFF Inc NITO.O: N2OFF ANNOUNCES CLOSING OF MERGER WITH DRUG DISCOVERY COMPANY TARGETING RESISTANT CANCERS INCLUDING PANCREATIC AND NON-SMALL CELL LUNG CANCER Source text: ID:nGNX6SKzBb Further company coverage: NITO.O ((Reuters.Briefs@thomsonreuters.com;))